ANTITUMOR ACTIVITY OF NAB-PACLITAXEL AND BEVACIZUMAB AGAINST A NEW TRIPLE NEGATIVE BREAST CANCER MODEL

被引：0
|
作者：
Trieu, V. [1 ]
Blackwell, K. L. [2 ]
Volk, L. [2 ]
Wilber, A. [2 ]
Desai, N. [1 ]
机构：
[1] Abraxis BioSci, Randd, Los Angeles, CA USA
[2] So Illinois Univ, Sch Med, Springfield, IL USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] Combination of nab-Paclitaxel and Bevacizumab Inhibited Tumor Growth and Metastasis of a New Triple Negative Breast Cancer Model
    Ran, S.
    Trieu, V.
    Volk, L. D.
    Wilber, A.
    Desai, N.
    CANCER RESEARCH, 2010, 70
  • [2] Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer
    Hamilton, Erika
    Kimmick, Gretchen
    Hopkins, Judith
    Marcom, P. Kelly
    Rocha, Gloria
    Welch, Renee
    Broadwater, Gloria
    Blackwell, Kimberly
    CLINICAL BREAST CANCER, 2013, 13 (06) : 416 - 420
  • [3] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Schmid, P.
    Adams, S.
    Rugo, H. S.
    Schneeweiss, A.
    Barrios, C. H.
    Iwata, H.
    Dieras, V.
    Hegg, R.
    Im, S. -A.
    Wright, G. Shaw
    Henschel, V.
    Molinero, L.
    Chui, S. Y.
    Funke, R.
    Husain, A.
    Winer, E. P.
    Loi, S.
    Emens, L. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2108 - 2121
  • [4] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 986 - 987
  • [5] Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer REPLY
    Schmid, Peter
    Chui, Stephen Y.
    Emens, Leisha A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 987 - 988
  • [6] Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
    Arpino, Grazia
    De Placido, Sabino
    De Angelis, Carmine
    ANTI-CANCER DRUGS, 2015, 26 (01) : 117 - 122
  • [7] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Kang, Connie
    Syed, Yahiya Y.
    DRUGS, 2020, 80 (06) : 601 - 607
  • [8] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Connie Kang
    Yahiya Y. Syed
    Drugs, 2020, 80 : 601 - 607
  • [9] Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
    Sun, Si
    Tang, Lichen
    Zhang, Jian
    Lv, Fangfang
    Wang, Zhonghua
    Wang, Leiping
    Zhang, Qunling
    Zheng, Chunlei
    Qiu, Lixin
    Jia, Zhen
    Lu, Yunhua
    Liu, Guangyu
    Shao, Zhimin
    Wang, Biyun
    Hu, Xichun
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 : 1443 - 1451
  • [10] Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
    Wang, Hanwen
    Ma, Huilin
    Sove, Richard J.
    Emens, Leisha A.
    Popel, Aleksander S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
12345